Keyphrases
Kidney Outcomes
100%
Finerenone
100%
FIGARO
100%
Estimated Glomerular Filtration Rate
85%
Albumin-to-creatinine Ratio
57%
Kidney
42%
Composite Endpoint
28%
Confidence Interval
28%
Hazard Ratio
28%
Placebo
28%
Cardiovascular Risk
28%
Cardiovascular Outcomes
28%
Type 2 Diabetic Patients
28%
Chronic Kidney Disease
28%
Kidney Disease Progression
28%
Albuminuria
28%
Kidney Failure
28%
Renal Death
28%
Estimated Glomerular Filtration Rate Slope
28%
Cardiovascular Events
14%
Treatment Effect
14%
Incidence Rate
14%
Between-group Difference
14%
Low Incidence
14%
2-stage
14%
Relative Risk Reduction
14%
End-stage Kidney Disease
14%
FIDELIO-DKD
14%
Moderately Increased Albuminuria
14%
Medicine and Dentistry
Glomerular Filtration Rate
100%
Finerenone
100%
Creatinine
50%
Cardiovascular System
37%
Albuminuria
37%
Chronic Kidney Disease
37%
Placebo
25%
Patient with Type 2 Diabetes
25%
Hazard Ratio
25%
Renal Failure
25%
Cardiovascular Risk
12%
Nephropathy
12%
Treatment Effect
12%
End Stage Renal Disease
12%
Disease Exacerbation
12%
Relative Risk Reduction
12%
Pharmacology, Toxicology and Pharmaceutical Science
Finerenone
100%
Creatinine
57%
Chronic Kidney Failure
42%
Albuminuria
42%
Placebo
28%
Non Insulin Dependent Diabetes Mellitus
28%
Kidney Failure
28%
Cardiovascular Risk
14%
Kidney Disease
14%
End Stage Renal Disease
14%
Disease Exacerbation
14%